で公開中です！ 詳しく見る
MRKのアイコン

Merck
MRK

145.95 USD
+0.76
0.52%
終値時点 更新済み 10月16日 16:00 EDT
プレマーケット
時間外取引
145.26
-0.69
0.47%
1日
0.52%
5日間
0.14%
1か月
0.72%
3か月
14.35%
6か月
26.41%
年初来
37.11%
1年
73.92%
5年間
89.18%
10年間
148.64%
 

概要： Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. In cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 53% of the company's 2025 sales were generated from US human health (pharmaceuticals and vaccines).

従業員数： 75,000

ヘルスケア 医薬品メーカー（総合）

ニュース

ポジティブ
ニュートラル
ネガティブ
センチメント 3か月間
ポジティブ 53.3%
ニュートラル 37.9%
ネガティブ 8.7%
ポジティブ
Investors Business Daily
9 時間前
Merck Stock: Watch This Price, Prepare To Profit From This Trade
Merck stock has been in an uptrend. A bullish options strategy aims to profit if the drugmaker's stock keeps rising.
Merck Stock: Watch This Price, Prepare To Profit From This Trade
ニュートラル
24/7 Wall Street
12 時間前
The Stocks That Will Get Investors Home Safe When Tech Cracks
When tech stocks crack, most investors discover too late that their portfolios were far more concentrated than they realized.
The Stocks That Will Get Investors Home Safe When Tech Cracks
ポジティブ
Market Watch
昨日
Big pharma stocks near all-time highs as tech selloff pushes investors toward safer bets
Shares of AbbVie, Eli Lilly and Gilead Sciences are trading at or near record highs.
Big pharma stocks near all-time highs as tech selloff pushes investors toward safer bets
ニュートラル
Barrons
昨日
Why Healthcare Stocks Are Hot When the AI Trade Runs Cold
Healthcare—particularly equipment and services and pharmaceuticals—offers investors diversification from AI, according to one report.
Why Healthcare Stocks Are Hot When the AI Trade Runs Cold
ポジティブ
Schwab Network
昨日
The Big 3: MRK, GILD, XOM
The significant rotation in the AI trade, particularly in neoclouds like CoreWeave (CRVW), is something Dan Deming believes opens the door to new trading opportunities. He sees Merck (MRK) leading a stabilizing healthcare sector, Gilead Sciences (GILD) as a stock "poised to continue upward price action," and Exxon Mobil (XOM) as a high-liquid name in a booming energy trade.
The Big 3: MRK, GILD, XOM
ポジティブ
24/7 Wall Street
昨日
AMGN vs. MRK: Which Pharma Giant's Dividend Actually Has Room to Grow
Amgen and Merck both yield around 2.3% and have surged this year, but one of them is paying its dividend out of thin air while the other has a cash cushion that changes the entire income calculus.
AMGN vs. MRK: Which Pharma Giant's Dividend Actually Has Room to Grow
ポジティブ
Zacks Investment Research
昨日
Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock
Merck (MRK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock
ポジティブ
CNBC
一昨日
Merck CEO tells CNBC he expects breakthrough cancer vaccine will become faster to make
Merck CEO Rob Davis told CNBC that he expects the company's breakthrough cancer vaccine with Moderna to get faster to make over time. Davis acknowledged that manufacturing the vaccine is a "complex system," but said Merck and Moderna have the process "down to a very tight science.
Merck CEO tells CNBC he expects breakthrough cancer vaccine will become faster to make
ポジティブ
Zacks Investment Research
一昨日
Will Keytruda Continue to Aid Merck's Top Line in Q3 Earnings?
MRK's Keytruda sales growth, earlier-stage launches and expanded indications could boost Q3 results, but biosimilar competition looms in 2028-2029.
Will Keytruda Continue to Aid Merck's Top Line in Q3 Earnings?
ニュートラル
Zacks Investment Research
3 日前
Merck (MRK) Dips More Than Broader Market: What You Should Know
Merck (MRK) concluded the recent trading session at $141.98, signifying a -2.39% move from its prior day's close.
Merck (MRK) Dips More Than Broader Market: What You Should Know
ニュースランキングを見る
価格チャートは Lightweight Charts™ を使用して実装されています